ReviewFrontiers in cell and developmental biology2026
Research advances in extracellular vesicles for diagnosis and treatment of genitourinary cancers.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) have emerged as vital mediators of intercellular communication, playing crucial roles in the initiation, progression, and metastasis of urogenital cancers. Due to their ability to carry diverse biological molecules and their excellent biocompatibility, EVs have garnered significant attention as novel tools for the diagnosis and treatment of malignancies such as prostate, bladder, kidney, and testicular cancers. This review summarizes recent progress in understanding the biological functions of EVs in various urogenital tumors, integrates findings from both fundamental studies and clinical trials, and discusses ongoing obstacles and future prospects in the field. By providing insights into the diagnostic and therapeutic applications of EVs, this article aims to support the development of precision medicine strategies for urogenital cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.